BANK VONTOBEL/CALL/MERCK & CO./145/0.1/20.12.24 Share Price

Warrant

DE000VD3SE30

Market Closed - Boerse Frankfurt Warrants 18:55:29 21/05/2024 BST
0.3 EUR -6.25% Intraday chart for BANK VONTOBEL/CALL/MERCK & CO./145/0.1/20.12.24
Current month-9.09%
1 month+3.45%
Date Price Change
21/05/24 0.3 -6.25%
20/05/24 0.32 +6.67%
17/05/24 0.3 -3.23%
16/05/24 0.31 -3.13%
15/05/24 0.32 +28.00%

Real-time Boerse Frankfurt Warrants

Last update May 21, 2024 at 06:55 pm

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying MERCK & CO., INC.
IssuerLogo Issuer Vontobel Vontobel
WKN VD3SE3
ISINDE000VD3SE30
Date issued 09/04/2024
Strike 145 $
Maturity 20/12/2024 (213 Days)
Parity 10 : 1
Emission price 0.28
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.41
Lowest since issue 0.24
Spread 0.01
Spread %3.23%

Company Profile

Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows: - sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.; - sale of vaccines (18%); - sale of animal health products (9.4%); - other (2.9%). Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
More about the company

Ratings for Merck & Co., Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Merck & Co., Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
130.8 USD
Average target price
141.6 USD
Spread / Average Target
+8.32%
Consensus